CVR Q3 2023 Earnings Narrowing Loss Amid Stable Operations Arcturus Therapeutics Holdings Inc ARCT Q1 2026 Earnings EPS Beat Narrowed Net Loss No Revenue Reported ESAB Q1 2026 Earnings EPS Slightly Misses Expectations Amid Steady Execution SOPA Q3 2025 Earnings EPS Falls Far Below Estimates Revenue Not Disclosed OXLC Q4 2025 Earnings EPS Misses Estimates as Net Investment Income Falls Short SNTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase